HER2-Positive Breast Cancer | Meet The Professor: Optimizing the Selection and Sequencing of Therapy for Patients with HER2-Positive Breast Cancer — Part 3 of a 6-Part Series

Featuring perspectives from Dr Erika Hamilton, including the following topics: Introduction (0:00) Case: A woman in her early 50s with metastatic HER2-positive breast cancer — Nick Leasure, MD (19:02) Case: A woman in her mid-50s with metastatic ER/PR-negative, HER2-positive breast cancer — Estelamari Rodriguez, MD, MPH (22:08) Cases: Three patients with metastatic HER2-positive disease — Kapisthalam (KS) Kumar, MD (24:43) Case: A woman in her early 40s with localized ER/PR-negative, HER2-positive breast cancer — Dr Leasure (31:55) Case: A woman in her late 30s with localized triple-positive breast cancer — Ruth O’Regan, MD (36:34) Case: A woman in her late 40s with localized ER/PR-positive, HER2-positive breast cancer and residual disease — Dr Leasure (40:17) Case: A woman in her early 60s with high-risk, localized ER-positive, HER2-positive breast cancer — Debra Patt, MD, PhD, MBA (44:08) Journal Club with Dr Hamilton (46:00) Beyond the Guidelines (54:06) CME information and select publications